FindTrial
Sign In

Vaitarana Basti and Shatpushpadi lepa in Arthritis (Amavata)

Comparative clinical evaluation of Vaitarana Basti and Shatpushpadi lepa in Amavata (Rheumatoid Arthritis) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055850
Enrollment
40
Registered
2023-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having sign and symptoms of Amavata (Rheumatoid arthritis). 2. Patients of age between 20 years to 50 years will be included. 3. Patients with less than 5 years of chronicity. 4. Patients able to participate in study and ready to follow the instruction.

Exclusion criteria

Exclusion criteria: 1. Patients with joint deformity. 2.Uncontrolled diabetes mellitus, Hypertension & life threatening disease. 3. Patients having dermatomyositis, scleroderma, acute rheumatic fever , gouty arthritis. 4. Patients having Skin allergy and hypersensitivity. 5. Pregnant and lactating women

Design outcomes

Secondary

MeasureTime frame
Exacerbation in sign & symptomsTimepoint: 60 days—

Primary

MeasureTime frame
Complete remission: 100% Marked improvement: 75% Moderate improvement: 51%-75% Mild improvement: 26%-50% No improvement: 0-25% Timepoint: 0th, 30th, 60th day—

Countries

India

Contacts

Public ContactSanjna Sharma

Rishikul Campus Haridwar

kripayanam@yahoo.com9758264164

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026